1,668 reports of this reaction
3.6% of all MECLIZINE HYDROCHLORIDE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for MECLIZINE HYDROCHLORIDE, manufactured by Aurobindo Pharma Limited. There are 1,668 FDA adverse event reports linking MECLIZINE HYDROCHLORIDE to NAUSEA. This represents approximately 3.6% of all 45,890 adverse event reports for this drug.
Patients taking MECLIZINE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among MECLIZINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for MECLIZINE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,668 FDA reports for MECLIZINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.6% of all adverse event reports for MECLIZINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking MECLIZINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.